Halper Sadeh Probes DexCom Board Over Fiduciary Duty Claims
New York – September 10, 2026 -- Halper Sadeh LLC has launched an investigation into whether officers and directors of DexCom, Inc. (NASDAQ: DXCM) breached their fiduciary duties to shareholders.
Law Firm Targets DexCom Governance Practices
The New York-based investor rights firm, operating out of One World Trade Center, is examining potential corporate misconduct at the continuous glucose monitoring device maker. Attorneys Daniel Sadeh and Zachary Halper are leading the inquiry.
Long-Term Shareholders Invited to Seek Governance Reforms
DexCom shareholders who have held stock long-term may pursue corporate governance reforms, the return of funds to the company, or a court-approved financial incentive award, according to the firm. Halper Sadeh LLC is offering to represent affected shareholders on a contingent fee basis, meaning clients would not bear out-of-pocket legal costs or expenses.